Literature DB >> 8096628

Multiple signaling pathways in bovine chromaffin cells regulate tyrosine hydroxylase phosphorylation at Ser19, Ser31, and Ser40.

J W Haycock1.   

Abstract

Intact bovine adrenal medullary chromaffin cells were preincubated with 32PO4, and the multiple-site phosphorylation of tyrosine hydroxylase (TH) was studied. Up to eight 32P-labeled peptides were produced by tryptic hydrolysis of TH; however, all of the tryptic phosphopeptides were derived from four phosphorylation sites--Ser8, Ser19, Ser31 and Ser40. In situ regulation of 32P incorporation into the latter three sites was demonstrated with a diverse set of pharmacological agents. 32P incorporation into Ser19 was preferentially increased by brief exposures to depolarizing secretagogues. Longer treatments also increased Ser31 and Ser40 phosphorylation. Nicotine, muscarine and vasoactive intestinal polypeptide--reflecting cholinergic and non-cholinergic components of sympatho-adrenal transmission--each produced different patterns of multiple-site phosphorylation of TH. Nicotine, bradykinin and histamine increased 32P incorporation at each of the three sites whereas muscarine, angiotensin II, endothelin III, prostaglandin E1, GABA and ATP selectively increased Ser31 phosphorylation. Nerve growth factor did not influence TH phosphorylation in chromaffin cells from adult adrenal glands but selectively increased Ser31 phosphorylation in chromaffin cells isolated from calf adrenal glands. 32P incorporation into Ser40 was selectively increased by forskolin and other cAMP-acting agents whereas vasoactive intestinal polypeptide increased Ser31 and Ser40 phosphorylation. Thus, the phosphorylation of TH in bovine chromaffin cells appears to be regulated at three sites by three separate intracellular signaling pathways--Ser19 via Ca2+/calmodulin-dependent protein kinase II; Ser31 via ERK (MAP2 kinases); and Ser40 via cAMP-dependent protein kinase. These signaling pathways, as well as the extracellular signals that were effective in stimulating them, are similar to those previously described for TH in rat pheochromocytoma cells. However, several of the pharmacological agents produced different patterns of multiple-site TH phosphorylation in the bovine chromaffin cells. These differences between tissues could be accounted for by differences in the coupling/access between the extracellular signal transduction systems and the intracellular signaling pathways as opposed to differences in the intracellular signaling pathways per se.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8096628     DOI: 10.1007/bf00966919

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  50 in total

1.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

Authors:  M A Markwell; S M Haas; L L Bieber; N E Tolbert
Journal:  Anal Biochem       Date:  1978-06-15       Impact factor: 3.365

Review 2.  Acute regulation of tyrosine hydroxylase by nerve activity and by neurotransmitters via phosphorylation.

Authors:  R E Zigmond; M A Schwarzschild; A R Rittenhouse
Journal:  Annu Rev Neurosci       Date:  1989       Impact factor: 12.449

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Both short- and long-term effects of nerve growth factor on tyrosine hydroxylase in calf adrenal chromaffin cells are blocked by S-adenosylhomocysteine hydrolase inhibitors.

Authors:  A Acheson; H Thoenen
Journal:  J Neurochem       Date:  1987-05       Impact factor: 5.372

5.  Stimulus-responsive and rapid formation of inositol pentakisphosphate in cultured adrenal chromaffin cells.

Authors:  N Sasakawa; T Nakaki; R Kato
Journal:  J Biol Chem       Date:  1990-10-15       Impact factor: 5.157

6.  Multiple site phosphorylation of tyrosine hydroxylase. Differential regulation in situ by a 8-bromo-cAMP and acetylcholine.

Authors:  J W Haycock; W F Bennett; R J George; J C Waymire
Journal:  J Biol Chem       Date:  1982-11-25       Impact factor: 5.157

7.  Nerve growth factor does not activate Na+/H+ exchange in PC12 pheochromocytoma cells.

Authors:  C E Chandler; E J Cragoe; L Glaser
Journal:  J Cell Physiol       Date:  1985-12       Impact factor: 6.384

8.  Activation and multiple-site phosphorylation of tyrosine hydroxylase in perfused rat adrenal glands.

Authors:  J W Haycock; A R Wakade
Journal:  J Neurochem       Date:  1992-01       Impact factor: 5.372

9.  Isolation and nucleotide sequence of a cDNA clone encoding bovine adrenal tyrosine hydroxylase: comparative analysis of tyrosine hydroxylase gene products.

Authors:  S R D'Mello; E P Weisberg; M K Stachowiak; L M Turzai; A E Gioio; B B Kaplan
Journal:  J Neurosci Res       Date:  1988-04       Impact factor: 4.164

10.  Identification of an activator of the microtubule-associated protein 2 kinases ERK1 and ERK2 in PC12 cells stimulated with nerve growth factor or bradykinin.

Authors:  N G Ahn; D J Robbins; J W Haycock; R Seger; M H Cobb; E G Krebs
Journal:  J Neurochem       Date:  1992-07       Impact factor: 5.372

View more
  37 in total

Review 1.  Molecular mechanisms of lead neurotoxicity.

Authors:  J Bressler; K A Kim; T Chakraborti; G Goldstein
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

2.  CRF₂ mediates the increased noradrenergic activity in the hypothalamic paraventricular nucleus and the negative state of morphine withdrawal in rats.

Authors:  Javier Navarro-Zaragoza; Cristina Núñez; Jessica Ruiz-Medina; M Luisa Laorden; Olga Valverde; M Victoria Milanés
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

3.  Angiotensin II causes calcium entry into bovine adrenal chromaffin cells via pathway(s) activated by depletion of intracellular calcium stores.

Authors:  David A Powis; Mariann Zerbes; Lynn M Herd; Peter R Dunkley
Journal:  Neurochem Res       Date:  2003-09       Impact factor: 3.996

4.  Effects of nicotine administration on striatal dopamine signaling after traumatic brain injury in rats.

Authors:  Samuel S Shin; Eric R Bray; C Edward Dixon
Journal:  J Neurotrauma       Date:  2011-10-24       Impact factor: 5.269

Review 5.  Regulation of blood pressure and salt homeostasis by endothelin.

Authors:  Donald E Kohan; Noreen F Rossi; Edward W Inscho; David M Pollock
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

6.  Elevated glucocorticoid levels are responsible for induction of tyrosine hydroxylase mRNA expression, phosphorylation, and enzyme activity in the nucleus of the solitary tract during morphine withdrawal.

Authors:  Cristina Núñez; Anna Földes; Domingo Pérez-Flores; J Carlos García-Borrón; M Luisa Laorden; Krisztina J Kovács; M Victoria Milanés
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

7.  Protein kinase A and nicotinic activation of bovine adrenal tyrosine hydroxylase.

Authors:  P D Marley; K A Thomson; R A Bralow
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

8.  Transgenic Mice Expressing Human α-Synuclein in Noradrenergic Neurons Develop Locus Ceruleus Pathology and Nonmotor Features of Parkinson's Disease.

Authors:  Laura M Butkovich; Madelyn C Houser; Termpanit Chalermpalanupap; Kirsten A Porter-Stransky; Alexa F Iannitelli; Jake S Boles; Grace M Lloyd; Alexandra S Coomes; Lori N Eidson; Maria Elizabeth De Sousa Rodrigues; Danielle L Oliver; Sean D Kelly; Jianjun Chang; Nora Bengoa-Vergniory; Richard Wade-Martins; Benoit I Giasson; Valerie Joers; David Weinshenker; Malú Gámez Tansey
Journal:  J Neurosci       Date:  2020-08-31       Impact factor: 6.167

Review 9.  Tyrosine hydroxylase and Parkinson's disease.

Authors:  J Haavik; K Toska
Journal:  Mol Neurobiol       Date:  1998-06       Impact factor: 5.590

10.  The low affinity dopamine binding site on tyrosine hydroxylase: the role of the N-terminus and in situ regulation of enzyme activity.

Authors:  Sarah L Gordon; Julianne K Webb; Jacqueline Shehadeh; Peter R Dunkley; Phillip W Dickson
Journal:  Neurochem Res       Date:  2009-05-16       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.